^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LB101

    i
    Other names: LB101, PD-L1xCD47 LockBody
    Associations

    News

    Trials
    Company:
    Centessa
    Drug class:
    PD-L1 inhibitor, CD47 inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=180, Recruiting, Centessa Pharmaceuticals (UK) Limited
    New P1/2 trial • Metastases
    |
    PD-L1 (Programmed death ligand 1) • MSI (Microsatellite instability)
    |
    PD-L1 expression
    |
    LB101